Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Published:2008-08 Issue:4 Volume:1 Page:415-423
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Chia Stanley,Senatore Fred,Raffel O. Christopher,Lee Hang,Wackers Frans J. Th.,Jang Ik-Kyung

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man;Hackel;Circulation,1984

2. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials;Keeley;Lancet,2003

3. It's time for a change to a troponin standard;Jaffe;Circulation,2000

4. Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction;Turer;Curr Control Trials Cardiovasc Med,2005

5. The quantification of infarct size;Gibbons;J Am Coll Cardiol,2004

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second peak of myocardial markers predicts in-hospital adverse outcomes after primary PCI for ST-segment elevation myocardial infarction;2024-08-26

2. Effects of mild hypercapnia on myocardial injury after out-of-hospital cardiac arrest. A sub-study of the TAME trial;Resuscitation;2024-08

3. STEMI, Revascularization, and Peak Troponin by Adverse Pregnancy Outcomes in Women With Myocardial Infarction;JACC: Advances;2024-08

4. Adaptability of prognostic prediction models for patients with acute coronary syndrome during the COVID-19 pandemic;BMJ Health & Care Informatics;2024-07

5. Infliximab Limits Injury in Myocardial Infarction;Journal of the American Heart Association;2024-05-07